Literature DB >> 31054608

Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

Nathan P Staff1, David T Jones2, Wolfgang Singer2.   

Abstract

Mesenchymal stromal cells are multipotent cells that are being used to treat a variety of medical conditions. Over the past decade, there has been considerable excitement about using MSCs to treat neurodegenerative diseases, which are diseases that are typically fatal and without other robust therapies. In this review, we discuss the proposed MSC mechanisms of action in neurodegenerative diseases, which include growth factor secretion, exosome secretion, and attenuation of neuroinflammation. We then provide a summary of preclinical and early clinical work on MSC therapies in amyotrophic lateral sclerosis, multiple system atrophy, Parkinson disease, and Alzheimer disease. Continued rigorous and controlled studies of MSC therapies will be critical in order to establish efficacy and protect patients from possible untoward effects.
Copyright © 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31054608      PMCID: PMC6643282          DOI: 10.1016/j.mayocp.2019.01.001

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  189 in total

1.  Neuronal to oligodendroglial α-synuclein redistribution in a double transgenic model of multiple system atrophy.

Authors:  Edward Rockenstein; Kiren Ubhi; Chandra Inglis; Michael Mante; Christina Patrick; Anthony Adame; Eliezer Masliah
Journal:  Neuroreport       Date:  2012-03-07       Impact factor: 1.837

2.  Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP/PS1 Alzheimer mice.

Authors:  Y Naaldijk; C Jäger; C Fabian; C Leovsky; A Blüher; L Rudolph; A Hinze; A Stolzing
Journal:  Neuropathol Appl Neurobiol       Date:  2016-04-19       Impact factor: 8.090

3.  MSC-based product characterization for clinical trials: an FDA perspective.

Authors:  Michael Mendicino; Alexander M Bailey; Keith Wonnacott; Raj K Puri; Steven R Bauer
Journal:  Cell Stem Cell       Date:  2014-02-06       Impact factor: 24.633

Review 4.  Innate immunity in Alzheimer's disease.

Authors:  Michael T Heneka; Douglas T Golenbock; Eicke Latz
Journal:  Nat Immunol       Date:  2015-03       Impact factor: 25.606

5.  Dopaminergic Induction of Umbilical Cord Mesenchymal Stem Cells by Conditioned Medium of Choroid Plexus Epithelial Cells Reduces Apomorphine-Induced Rotation in Parkinsonian Rats.

Authors:  Abbas Aliaghaei; Mossa Gardaneh; Nader Maghsoudi; Parvin Salehinejad; Ehsan Gharib
Journal:  Arch Iran Med       Date:  2016-08       Impact factor: 1.354

6.  Microglial activation parallels system degeneration in multiple system atrophy.

Authors:  Keisuke Ishizawa; Takashi Komori; Shoichi Sasaki; Nobutaka Arai; Toshio Mizutani; Takanori Hirose
Journal:  J Neuropathol Exp Neurol       Date:  2004-01       Impact factor: 3.685

7.  Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS.

Authors:  Nathan P Staff; Nicolas N Madigan; Jonathan Morris; Mark Jentoft; Eric J Sorenson; Greg Butler; Dennis Gastineau; Allan Dietz; Anthony J Windebank
Journal:  Neurology       Date:  2016-10-26       Impact factor: 9.910

8.  Opposite effects of bone marrow-derived cells transplantation in MPTP-rat model of Parkinson's disease: a comparison study of mononuclear and mesenchymal stem cells.

Authors:  Caroline Santos Capitelli; Carolina Salomão Lopes; Angélica Cristina Alves; Janaína Barbiero; Lucas Felipe Oliveira; Valdo José Dias da Silva; Maria Aparecida Barbato Frazão Vital
Journal:  Int J Med Sci       Date:  2014-08-03       Impact factor: 3.738

Review 9.  NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

10.  Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy.

Authors:  Nadia Stefanova; Markus Reindl; Manuela Neumann; Philipp J Kahle; Werner Poewe; Gregor K Wenning
Journal:  Mov Disord       Date:  2007-11-15       Impact factor: 10.338

View more
  36 in total

1.  Transplantation of Nasal Olfactory Mucosa Mesenchymal Stem Cells Benefits Alzheimer's Disease.

Authors:  Chun-Gu Hong; Meng-Lu Chen; Ran Duan; Ming Lu; Hui Xie; Zheng-Zhao Liu; Xin Wang; Zhi-Lin Pang; Li-Te Ge
Journal:  Mol Neurobiol       Date:  2022-09-29       Impact factor: 5.682

Review 2.  Exosomes in schizophrenia: Pathophysiological mechanisms, biomarkers, and therapeutic targets.

Authors:  Yu Wang; Nousayhah Amdanee; Xiangrong Zhang
Journal:  Eur Psychiatry       Date:  2022-09-09       Impact factor: 7.156

Review 3.  Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors.

Authors:  Jie Wang; Wei-Wei Hu; Zhi Jiang; Mei-Jiang Feng
Journal:  World J Stem Cells       Date:  2020-05-26       Impact factor: 5.326

4.  Latent Tri-lineage Potential of Human Menstrual Blood-Derived Mesenchymal Stromal Cells Revealed by Specific In Vitro Culture Conditions.

Authors:  Diana Quintero-Espinosa; Viviana Soto-Mercado; Catherine Quintero-Quinchia; Carlos Velez-Pardo; Miguel Mendivil-Perez; Marlene Jimenez-Del-Rio
Journal:  Mol Neurobiol       Date:  2021-07-16       Impact factor: 5.590

Review 5.  MSCs and Inflammatory Cells Crosstalk in Regenerative Medicine: Concerted Actions for Optimized Resolution Driven by Energy Metabolism.

Authors:  Valerie Planat-Benard; Audrey Varin; Louis Casteilla
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

6.  Therapeutic potential of dental pulp stem cell transplantation in a rat model of Alzheimer's disease.

Authors:  Xue-Mei Zhang; Yuan-Jiao Ouyang; Bing-Qian Yu; Wei Li; Mei-Yu Yu; Jin-Yue Li; Zhuo-Min Jiao; Dan Yang; Na Li; Ying Shi; Yun-Yun Xu; Zhi-Jun He; Duo Wang; Hui Yue; Jin Fu
Journal:  Neural Regen Res       Date:  2021-05       Impact factor: 5.135

Review 7.  New therapeutic approaches of mesenchymal stem cells-derived exosomes.

Authors:  Jana Janockova; Lucia Slovinska; Denisa Harvanova; Timea Spakova; Jan Rosocha
Journal:  J Biomed Sci       Date:  2021-05-25       Impact factor: 8.410

Review 8.  Clinical update on the use of mesenchymal stem cells in COVID-19.

Authors:  Fatima A Saleh; Joyce Ghazzawi
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

9.  Icariside II promotes the differentiation of human amniotic mesenchymal stem cells into dopaminergic neuron-like cells.

Authors:  Wei Kuang; Tao Liu; Fang He; Limei Yu; Qian Wang; Changyin Yu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-03-15       Impact factor: 2.416

Review 10.  HGF and MET: From Brain Development to Neurological Disorders.

Authors:  Claudia Desole; Simona Gallo; Annapia Vitacolonna; Francesca Montarolo; Antonio Bertolotto; Denis Vivien; Paolo Comoglio; Tiziana Crepaldi
Journal:  Front Cell Dev Biol       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.